secwatch.observer — SEC 8-K summary
======================================

Issuer:     Aura Biosciences, Inc. (AURA)
CIK:        0001501796
Form:       8-K
Filed at:   2023-06-07T23:59:59+00:00
Accession:  0001193125-23-162617
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Aura Biosciences shareholders elect David Johnson and Karan Takhar as directors, ratify EY auditor
--------------------------------------------------------------------------------

- At the annual meeting on June 7, 2023, shareholders elected David Johnson and Karan Takhar as Class II directors until 2026, with over 13.2 million votes for each.
- The appointment of Ernst & Young as independent auditor for fiscal year 2023 was ratified with 25,725,525 votes for, 3,721 against, and 1,826 abstentions.
- Broker non-votes on director elections totaled 9,206,963; there were no broker non-votes on auditor ratification.
- Total shares present or represented were 25,731,072 out of 37,800,102 entitled to vote.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1501796/000119312523162617/0001193125-23-162617-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1501796/000119312523162617/d489468d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-23-162617

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer